Semnur Pharmaceuticals, Inc.
SMNR
$0.55
-$0.01-1.79%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -10.12% | -39.20% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.69% | -25.69% | |||
| Operating Income | 7.69% | 25.69% | |||
| Income Before Tax | 5.00% | 25.69% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.00% | 25.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.00% | 25.69% | |||
| EBIT | 7.69% | 25.69% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 5.03% | 29.68% | |||
| Normalized Basic EPS | 4.84% | 29.94% | |||
| EPS Diluted | 5.03% | 29.68% | |||
| Normalized Diluted EPS | 4.84% | 29.94% | |||
| Average Basic Shares Outstanding | 0.00% | 5.88% | |||
| Average Diluted Shares Outstanding | 0.00% | 5.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||